Endovascular treatment for superior vena cava obstruction
Journal Title: Postępy Nauk Medycznych - Year 2015, Vol 28, Issue 2
Abstract
Introduction. Superior vena cava syndrome (SVCS) is common complication of malignancy, the lung cancer is the most common cause. The clinical indication for superior vena cava (SVC) endovascular treatment is allevation of superior vena cava syndrome (SVCS) caused by malignant obstruction.Aim. Evaluation of safety and efficacy of SVC stenting in patients with malignant superior vena cava syndrome (SVCS) – our experience.Material and methods. Between 2011 and 2014, data of 112 patients with SVC syndrome, mostly of malignant aetiology, were retrospectively collected. The study included 68 men and 44 women (mean age – 64; range 43-79 years).Results. Stent placement was technically successful in 98% cases. Two stents were found to be obstructed after several months and patients needed repeated angioplasty. There was no stent migration to the right atrium. Haemoptysis was observed in one patient and pulmonary embolism in two cases. There were no major remote complications.Conclusions. Endovascular stenting has become a safe and cost effective treatment for patients with SVCS, providing rapid relief of symptoms and improving their quality of life. Endovascular stenting should be performed in each patient with SVCS.
Authors and Affiliations
Monika Miazga, Tomasz Jargiełło, Anna Drelich-Zbroja, Klaudia Karska, Krzysztof Pyra, Michał Sojka, Marcin Kowalik, Małgorzata Szczerbo-Trojanowska
Keywords
Related Articles
- EP ID EP54992
- DOI -
- Views 165
- Downloads 0
Primary immunologic thrombocytopenia (ITP) – the dawning of the thrombopoetin-receptor agonists
Recent research on the pathogenesis of chronic immune thrombocytopenia (ITP) points to a role of suboptimal platelet production. The development of of thrombopoietin-mimetic agents, which can increase platelet count by i...
Endovascular mechanical thrombectomy of primary and recurrent changes in the arteries and bypasses – preliminary own experience
Introduction. Atherosclerosis is the most common disease of lower extremity arteries and a main cause of chronic limb ischemia. Treatment options of advanced peripheral arterial disease include surgical methods (endarter...
Stężenie karnityny w surowicy krwi u dzieci z zespołem nerczycowym
<b>Wstęp. </b>Karnityna jest czwartorzędową aminą biogenną, której kluczowa funkcja w organizmie polega na udziale w metabolizmie lipidów. Zaburzenia gospodarki lipidowej to jeden z głównych o...
Płucna histiocytoza z komórek Langerhansa
Płucna postać histiocytozy z komórek Langerhansa (ang. pulmonary Langerhans’ cell histiocytosis – PLCH) jest jedną z chorób śródmiąższowych płuc związanych z paleniem tytoniu. Obraz histologiczny PLCH charakteryzuje się...
Znaczenie badania czynników prognostycznych przy rozpoznaniu przewlekłej białaczki limfocytowej